Medtronic (MDT)

Cash & Short-Term Investments

$8.82B

Quarterly · Period ending: · USD

MDT logo

MDT Cash & Short-Term Investments

Latest reported$8.82B
MDT Quarterly Cash & Short-Term Investments ($135.40M → $8.82B)
High-resolution chart · PNG

MDT cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Medtronic Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
8,819,000,000
9,220,000,000
8,383,000,000
8,327,000,000
8,121,000,000
8,965,000,000
7,922,000,000
7,989,000,000
7,843,000,000
8,005,000,000
8,321,000,000
7,734,000,000
7,876,000,000
7,959,000,000
11,137,000,000
11,430,000,000
8,873,000,000
10,573,000,000
11,221,000,000
10,669,000,000
10,595,000,000
10,817,000,000
14,639,000,000
14,277,000,000
13,012,000,000
10,948,000,000
11,628,000,000
10,398,000,000
10,683,000,000
9,848,000,000
9,142,000,000
10,133,000,000
11,004,000,000
11,227,000,000
14,436,000,000
13,526,000,000
13,088,000,000
13,708,000,000
11,458,000,000
11,257,000,000
12,810,000,000
12,634,000,000
17,286,000,000
17,229,000,000
17,982,000,000
19,480,000,000
31,148,000,000
14,464,000,000
13,962,000,000
14,241,000,000
13,667,000,000
12,584,000,000
11,331,000,000
11,071,000,000
2,464,000,000
2,675,000,000
2,491,000,000
2,592,000,000
2,345,000,000
2,166,000,000
2,521,000,000
2,428,000,000
3,467,000,000
3,544,000,000
3,917,000,000
3,775,000,000
2,292,000,000
1,542,000,000
1,544,000,000
1,676,000,000
1,743,000,000
1,042,000,000
1,745,000,000
1,613,000,000
1,307,000,000
5,583,000,000
2,813,000,000
3,078,000,000
3,321,000,000
3,605,000,000
5,945,000,000
6,101,400,000
4,926,800,000
4,177,300,000
3,160,200,000
3,391,600,000
2,929,800,000
2,707,800,000
2,408,300,000
1,927,500,000
1,443,900,000
1,190,300,000
1,279,500,000
1,492,800,000
1,485,300,000
1,040,700,000
888,700,000
533,700,000
532,200,000
347,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.